To serve and neuroprotect

Nature Medicine

Volumn 18, Issue 7, 2012, Pages 1003-1006

  Dolgin, Elie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISUFENTON SODIUM; PLACEBO;

ARTICLE; CANADA; DRUG COST; DRUG INDUSTRY; DRUG TREATMENT FAILURE; HUMAN; MOTOR PERFORMANCE; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE; SYNAPSE;

ANIMALS; BENZENESULFONATES; CLINICAL TRIALS AS TOPIC; HAPLORHINI; HUMANS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; STROKE;

EID: 84863698256     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0712-1003     Document Type: Article

References (17)

1. World Health Organization. The 10 leading causes of death by broad income group http://www.who.int/mediacentre/factsheets/fs310/en/index.html (2008).
2. Lees, K.R. et al. N. Engl. J. Med. 354, 588-600 (2006).
3. Shuaib, A. et al. N. Engl. J. Med. 357, 562-571 (2007).
4. Sattler, R. et al. Science 284, 1845-1848 (1999).
5. Aarts, M. et al. Science 298, 846-850 (2002).
6. Sun, H.S. et al. Stroke 39, 2544-2553 (2008).
7. Stroke Therapy Academic Industry Roundtable (STAIR). Stroke 30, 2752-2758 (1999).
8. Fisher, M. et al. Stroke 40, 2244-2250 (2009).
9. Cook, D.J., Teves, L. & Tymianski, M. Nature 483, 213-217 (2012).
10. Bråtane B.T. et al. Stroke 42, 3265-3270 (2011).
11. Bach, A. et al. Proc. Natl. Acad. Sci. USA 109, 3317-3322 (2012).
12. Kawaguchi, A.T. et al. J. Pharmacol. Exp. Ther. 332, 429-436 (2010).
13. Umemura, K. et al. J. Nucl. Med. 46, 1931-1936 (2005).
14. Matsuura, S. et al. Brain Res. 1410, 122-131 (2011).
15. Furuichi, Y., Maeda, M., Matsuoka, N., Mutoh, S. & Yanagihara, T. Exp. Neurol. 204, 138-146 (2007).
16. Li, J. et al. Brain Res. 1334, 65-72 (2010).
17. Bahjat, F.R. et. al. J. Cereb. Blood Flow Metab. 31, 1229-1242 (2011).